Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Latigo Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | Other | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | Other | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | Other | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | Other | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | Buy | $2.5M | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | Other | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | Other | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | Other | — | SEC | |
Latigo Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
PARDES BIOSCIENCES, INC.Listing unverified | Award | — | SEC | |
PARDES BIOSCIENCES, INC.Listing unverified | AwardD (derivative) | — | SEC | |
PARDES BIOSCIENCES, INC.Listing unverified | OtherD (derivative) | — | SEC | |
PARDES BIOSCIENCES, INC.Listing unverified | Award | $10M | SEC | |
PARDES BIOSCIENCES, INC.Listing unverified | Other | — | SEC |